Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vikram Deshpande, M.B.,B.S.

Co-Author

This page shows the publications co-authored by Vikram Deshpande and Zachary Wallace.
Connection Strength

1.406
  1. Immunoglobulin G4-related Disease. Clin Chest Med. 2019 09; 40(3):583-597.
    View in: PubMed
    Score: 0.208
  2. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford). 2016 Jun; 55(6):1000-8.
    View in: PubMed
    Score: 0.163
  3. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015 Sep; 67(9):2466-75.
    View in: PubMed
    Score: 0.158
  4. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015 Jan; 74(1):190-5.
    View in: PubMed
    Score: 0.144
  5. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014 Jun; 43(6):806-17.
    View in: PubMed
    Score: 0.139
  6. IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore). 2013 Jul; 92(4):206-216.
    View in: PubMed
    Score: 0.136
  7. IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol. 2012 Jan-Feb; 57(1):26-33.
    View in: PubMed
    Score: 0.121
  8. Prostate and pancreas involvement are linked in IgG4-related disease. Semin Arthritis Rheum. 2020 12; 50(6):1245-1251.
    View in: PubMed
    Score: 0.056
  9. Lymphomas in IgG4-related disease: clinicopathologic features in a Western population. Virchows Arch. 2018 May; 472(5):839-852.
    View in: PubMed
    Score: 0.046
  10. Atypical IgG4+ Plasmacytic Proliferations and Lymphomas: Characterization of 11 Cases. Am J Clin Pathol. 2017 Sep 01; 148(3):215-235.
    View in: PubMed
    Score: 0.045
  11. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016 09; 138(3):825-838.
    View in: PubMed
    Score: 0.041
  12. Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al. Ann Rheum Dis. 2015 Aug; 74(8):e47.
    View in: PubMed
    Score: 0.038
  13. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015 Jun; 74(6):1171-7.
    View in: PubMed
    Score: 0.038
  14. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015 Dec; 74(12):2236-43.
    View in: PubMed
    Score: 0.037
  15. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014 Sep; 134(3):679-87.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.